High mortality and severe immunosuppression in hospitalized patients with pulmonary tuberculosis and HIV-2 infection in Guinea-Bissau

Scandinavian Journal of Infectious Diseases

Volumn 33, Issue 6, 2001, Pages 450-456

  Norrgren, H ^a   Bamba, S ^a   Da Silva, Z J ^a   Andersson, S ^a   Koivula, T ^a   Biberfeld, G ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE;

ADULT; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GUINEA-BISSAU; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOREACTIVITY; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; PATIENT CARE; PREDICTION; PREVALENCE; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK FACTOR; SPUTUM ANALYSIS; SURVIVAL; TREATMENT OUTCOME; TUBERCULIN TEST;

ADOLESCENT; ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; GUINEA-BISSAU; HIV INFECTIONS; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TUBERCULOSIS, PULMONARY;

EID: 0034959962     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540152029927     Document Type: Article

References (30)

1. The mortality and pathology of HIV infection in a West African city
2. Pulmonary tuberculosis in HIV-infected patients in Zaire: A controlled trial of treatment for either 6 or 12 months
3. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire
4. Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons
5. Two-year follow-up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa
6. Predictors of survival in HIV-infected tuberculosis patients
7. Site of disease and opportunistic infection predict survival in HIV-associated tuberculosis
8. A prospective study of tuberculosis and human immunodeficiency virus infection: Clinical manifestations and factors associated with survival
9. Pulmonary tuberculosis in Guinea-Bissau: Clinical and bacteriological findings, human immunodeficiency virus status and short term survival of hospitalized patients
10. Tuberculosis and human immunodeficiency virus infection in West Burkina Faso: Clinical presentation and clinical evolution
11. CD4 + lymphocyte count in African patients co-infected with HIV and tuberculosis
12. A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis. A single-blind randomized evaluation in Ugandan patients with HIV-1 tuberculosis
13. Towards a better understanding of the epidemiology of HIV-2
14. Trends and interaction of HIV-1 and HIV-2 in Guinea-Bissau, West Africa: No protection of HIV-2 against HIV-1 infection
15. Field evaluation of alternative testing strategies for diagnosis and differentiation of HIV-1 and HIV-2 infections in an HIV-1 and HIV-2-prevalent area
16. Serial CD4 and CD8 T-lymphocyte counts and associated mortality in an HIV-2-infected population in Guinea-Bissau
17. Rate of decline of percentage CD4+ cells is faster in HIV-1 than in HIV-2 infection
18. Rate of decline of CD4 cells in different stages of HIV-2 infection in a cohort of police officers in Guinea-Bissau
19. Reduced rate of disease development after HIV-2 infection as compared to HIV-1
20. HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4 + lymphopenia in HIV type 2-infected individuals
21. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: Significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection
22. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2
23. Lessons from the second AIDS virus, HIV-2
24. WHO case definitions for AIDS surveillance in adults and adolescents
25. A comparison of clinical features in tuberculosis associated with infection with human immunodeficiency viruses 1 and 2
26. Radiologic manifestations of pulmonary tuberculosis in HIV-1 and HIV-2-infected patients in Abidjan, Côte d'Ivoire
27. HIV-associated tuberculosis in developing countries: Clinical features, diagnosis, and treatment
28. Immunological findings in African patients with pulmonary tuberculosis and HIV-2 infection
29. Normalization of CD4+ T-lymphocyte depletion in patients without HIV infection treated for tuberculosis
30. Drug susceptibility in Mycobacterium tuberculosis of a sample of patients in Guinea Bissau